Chanokbhorn Phaosiri
7PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 30, 2025
Curcumin Derivative CU4c Exhibits HDAC-Inhibitory and Anticancer Activities Against Human Lung Cancer Cells In Vitro and in Mouse Xenograft Models.Narissara Namwan, Gulsiri Senawong, Chanokbhorn Phaosiri
|Feb 26, 2025
Synergistic Anti-Cancer Activities of Curcumin Derivative CU17 Combined with Gemcitabine Against A549 Non-Small-Cell Lung Cancer Cells.Narissara Namwan, Gulsiri Senawong, Chanokbhorn Phaosiri
|Nov 22, 2023
Evaluation and molecular docking study of two flavonoids from Oroxylum indicum (L.) Kurz and their semi-synthetic derivatives as histone deacetylase inhibitors.La-Or Somsakeesit, Thanaset Senawong, Gulsiri Senawong
|Jul 29, 2023
Tiliacora triandra Leaf Powder Ethanolic Extract in Combination with Cisplatin or Gemcitabine Synergistically Inhibits the Growth of Cholangiocarcinoma Cells In Vitro and in Nude Mouse Xenograft Models.Arunta Samankul, Gulsiri Senawong, Suppawit Utaiwat
|Jul 09, 2022
HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells.Narissara Namwan, Gulsiri Senawong, Chanokbhorn Phaosiri
Pageof 2